Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes

PLoS Pathog. 2013 Mar;9(3):e1003259. doi: 10.1371/journal.ppat.1003259. Epub 2013 Mar 21.

Abstract

HIV-1 latency remains a formidable barrier towards virus eradication as therapeutic attempts to purge these reservoirs are so far unsuccessful. The pool of transcriptionally silent proviruses is established early in infection and persists for a lifetime, even when viral loads are suppressed below detection levels using anti-retroviral therapy. Upon therapy interruption the reservoir can re-establish systemic infection. Different cellular reservoirs that harbor latent provirus have been described. In this study we demonstrate that HIV-1 can also establish a silent integration in actively proliferating primary T lymphocytes. Co-culturing of these proliferating T lymphocytes with dendritic cells (DCs) activated the provirus from latency. Activation did not involve DC-mediated C-type lectin DC-SIGN signaling or TCR-stimulation but was mediated by DC-secreted component(s) and cell-cell interaction between DC and T lymphocyte that could be inhibited by blocking ICAM-1 dependent adhesion. These results imply that circulating DCs could purge HIV-1 from latency and re-initiate virus replication. Moreover, our data show that viral latency can be established early after infection and supports the idea that actively proliferating T lymphocytes with an effector phenotype contribute to the latent viral reservoir. Unraveling this physiologically relevant purging mechanism could provide useful information for the development of new therapeutic strategies that aim at the eradication of HIV-1 reservoirs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation
  • Coculture Techniques
  • Dendritic Cells / immunology*
  • Dendritic Cells / metabolism
  • Dendritic Cells / virology
  • HEK293 Cells
  • HIV-1 / immunology*
  • HIV-1 / pathogenicity
  • Host-Pathogen Interactions*
  • Humans
  • Proviruses / physiology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / virology
  • Virus Activation / immunology*
  • Virus Latency

Grants and funding

Research of RMvdS and REJ was supported by the Dutch AIDS Fund (AIDS Fonds 2007028 and 2008014; http://www.aidsfonds.nl/about/organisation). RWS is a recipient of a Vidi grant from the Netherlands Organization for scientific research (NOW; http://www.nwo.nl/nwohome.nsf/pages/SPPD_5R2QE7_Eng) and a Starting Investigator grant from the European Research Council (ERC-StG-2011-280829-SHEV; http://erc.europa.eu/starting-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.